A Multiple Modality Approach for Targeting Chemotherapy-and Parpi-Resisatnt Ovarian Cancer

Grant number: MCRF19007 | Funding period: 2020 - 2021

Completed

Related publications (1)

Scholarly works icon

CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer

J Xuan, RB Pearson, E Sanij

2020-11-01

Acquired drug resistance leads to poor clinical outcome in high grade serous ovarian cancer (HGSOC). We have demonstrated the effi..

University of Melbourne Researchers